Lung cancer is the second most occurring cancer in the United States, behind
breast cancer, but it is by far the leading cause of death out of all types of cancer. As lung
cancer develops quickly, early detection is critical to a patient’s prognosis. Cancer is not
a uniform disease – a number of different mutations are associated with lung cancer. For
patients with some of these mutations, targeted therapies are available that provide a
better alternative to non-specific chemotherapy. In this project, I concentrate on three
mutations in lung cancer and work to develop a method of detection.